Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges about a group meeting with institutional investors and analysts scheduled for June 24, 2025. A total of 8 participants are listed, including B&K Securities, 3P Asset, Kotak Mutual Fund, SBI Pension, Mahindra Manulife, ITI MF, UTI MF, and Unifi Capital. The meeting is being held in a group format. The company has noted that the schedule is subject to change depending on circumstances. This is a routine regulatory disclosure filed under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30).
This is a routine investor engagement disclosure with no material business or financial information. It signals active communication with the institutional investor community but is unlikely to have any direct impact on the stock price.